WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutica...(their value through the development of p...),Health
Navigation Links
WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
Date:9/2/2008
their value through the development of product improvements and line extensions.
WellSpring is a privately held pharmaceutical company founded in 1999 by Dr. Robert A. Vukovich the firm's CEO and Chairman. Dr. Vukovich previously founded and managed Roberts Pharmaceutical Corporation of Eatontown, NJ until its acquisition by Shire Pharmaceutical Group in 1999. WellSpring owns and operates an FDA approved manufacturing plant in Oakville, Ontario, Canada. Its administrative headquarters are located in Bradenton, Florida. The firm provides contract manufacturing services to the pharmaceutical industry and manufactures prescription and OTC drug products for both the US and Canada.
Press - Dr. Robert A. Vukovich, +1-941-552-7880, or +1-941-504-1229, or Wendy Shusko, +1-941-552-7881. Canada: Bonnie Feeney +1-905-337-4500.
WellSpring Websites: http://www.wellspringpharm.com, http://www.wpcoutsourcing.com, http://www.wellskin.ca.
Information regarding several of the newly acquired brands can be found at the following web addresses: http://www.micatin.com and http://www.emetrol.com.
'/>"/>
| SOURCE WellSpring Pharmaceutical Corp. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. ISTA Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
3. Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters
4. Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction
5. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
6. Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
7. MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
8. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
9. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
10. MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results
11. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
Post Your Comments:
Breaking Medicine News(10 mins):Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:Pitt study suggests craving hinders comprehension without you realizing it 2Health News:Antidepressants May Change Your Personality 2Health News:Antidepressants May Change Your Personality 3Health News:Antidepressants May Change Your Personality 4Health News:Health Reform is About You and Me, Not One or the Other 2Health News:Health Reform is About You and Me, Not One or the Other 3Health News:Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients 2
[0] U.S. Cancer Cases, Deaths Continue to Drop [0] Pitt study suggests craving hinders comprehension without you realizing it[0] Antidepressants May Change Your Personality[1] Health Reform is About You and Me, Not One or the Other[1] Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients
Other Medicine News:Health News:Sleep Apnea Related To Death And Loss Of Brain Cells 2Health News:DNA Directory Under Construction For Indian Criminals ! 2Health News:Yet Another Use For Green Tea Extract 2
Breaking Medicine Technology:Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Working Women and Men Will Not Be Silenced by Right Wing Attack Dogs 3B SEIU Members and Other Working Americans Will Continue to Speak Out For the Am 57686 1Working Women and Men Will Not Be Silenced by Right Wing Attack Dogs 3B SEIU Members and Other Working Americans Will Continue to Speak Out For the Am 57686 2Solta Medical to Present at the Maxim Group Growth Conference 57684 1Solta Medical to Present at the Maxim Group Growth Conference 57684 2Gateway Responding To Increased Need for Treatment Among Middle Income Substance Abusers 57682 1Gateway Responding To Increased Need for Treatment Among Middle Income Substance Abusers 57682 2
Other Medicine Technology:Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 2Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 3Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 4Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 5Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome 6NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 2NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 3NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |